Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02884505 · ClinicalTrials.gov registry record
Improving the Assessment of Hypersomnolence
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 132
- Enrollment target
NCT02884505: Completed study, sponsored by University of Wisconsin, Madison.
NCT02884505 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02884505 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
The overall purpose of this study is to employ a pragmatic, multidimensional assessment of hypersomnolence that "piggybacks" on routine clinical care in patients with suspected disorders of central nervous system (CNS) hypersomnia, to determine whether these additional objective and subjective assessments are useful in the diagnosis and management of these patients.
Primary Outcome
Multiple measurements will be aggregated to arrive at the primary outcome of proportion of patients categorized as having hypersomnolence using either standard assessments or standard assessments plus additional novel hypersomnolence measures of pupillometry, psychomotor vigilance task, and auditory evoked potentials. Proportion of patients with hypersomnolence using standard measures will be calculated as number of patients with mean sleep latency (MSL) on multiple sleep latency test (MSLT) \<8
Interventions
- DEVICE Pupillometry
- BEHAVIORAL Psychomotor Vigilance Task
- OTHER Auditory Evoked Potential
- BEHAVIORAL Hypersomnia Severity Index
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2017-08-25 |
| Est. Completion | 2019-06-30 |
What the finished NCT02884505 record still lists
NCT02884505 is an observational study that tracks outcomes without assigning an intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 4 interventions - of which Pupillometry is the first listed.
NCT02884505 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02884505 about?
NCT02884505 is a clinical study titled "Improving the Assessment of Hypersomnolence". The overall purpose of this study is to employ a pragmatic, multidimensional assessment of hypersomnolence that "piggybacks" on routine clinical care in patients with suspected disorders of central nervous system (CNS) hypersomnia, to determine whether these additional objective and subjective asses...
What is the current status of trial NCT02884505?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2017-08-25. Estimated completion is 2019-06-30.
What interventions are being tested in trial NCT02884505?
The interventions under investigation include: Pupillometry (DEVICE), Psychomotor Vigilance Task (BEHAVIORAL), Auditory Evoked Potential (OTHER), Hypersomnia Severity Index (BEHAVIORAL).
Who is sponsoring clinical trial NCT02884505?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI